Biomarkers offer little help to cardiologists

New biomarkers being tracked for cardiac risk did help provide indicators of a person's condition, according to Harvard researchers. But the biomarkers currently offer little more than what physicians can already glean from a patients record for smoking, obesity, blood pressure and cholesterol levels. Article

Suggested Articles

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.

GigaGen joined a group of companies making plasma-based, polyclonal antibody treatments for COVID-19.